Eric A. Hoste

Eric A. Hoste

Intensive Care Medicine
Gent, VLG, BE 
Gent, VLG, BE 
OverviewLocationsClinical ResearchSimilar Doctors

Overview

Eric Hoste is an Intensive Care Medicine expert in Gent, Belgium. His top area of expertise is Liver Failure.

His clinical research consists of co-authoring 134 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Intensive Care Medicine
Gender
Male

Locations

Gent, VLG, Belgium
Other Locations
Brussels, BRU, Belgium
Mons, WAL, Belgium
VLG, Belgium
Kortrijk, VLG, Belgium

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

STandard Versus Accelerated Initiation of Renal Replacement Therapy in Acute Kidney Injury (STARRT-AKI): A Multi-Centre, Randomized, Controlled Trial (Principal Trial)
STandard Versus Accelerated Initiation of Renal Replacement Therapy in Acute Kidney Injury (STARRT-AKI): A Multi-Centre, Randomized, Controlled Trial (Principal Trial)
Enrollment Status: Completed
Publish Date: October 18, 2024
Intervention Type: Other
Study Phase: Not Applicable
Impact of Tight Blood Glucose Control Within Normal Fasting Ranges With Insulin Titration Prescribed by the Leuven Algorithm in Adult Critically Ill Patients
Impact of Tight Blood Glucose Control Within Normal Fasting Ranges With Insulin Titration Prescribed by the Leuven Algorithm in Adult Critically Ill Patients
Enrollment Status: Active_not_recruiting
Publish Date: June 05, 2023
Intervention Type: Drug
Study Phase: Phase 3
Early Goal Directed Therapy for Acute Kidney Injury
Early Goal Directed Therapy for Acute Kidney Injury
Enrollment Status: Withdrawn
Publish Date: December 20, 2022
Intervention Type: Procedure
Study Phase: Phase 2
Veno-venous Extracorporeal CO2 Removal in ARDS-patients to Treat Respiratory Acidosis.
Veno-venous Extracorporeal CO2 Removal in ARDS-patients to Treat Respiratory Acidosis.
Enrollment Status: Completed
Publish Date: December 15, 2022
Intervention Type: Procedure
Study Phase: Not Applicable
The Influence of Fluid Removal Using Continuous Venovenous Hemofiltration (CVVH) on Intra-abdominal Pressure and Kidney Function in Critically Ill Adults With Intra-abdominal Hypertension and Acute Kidney Injury
The Influence of Fluid Removal Using Continuous Venovenous Hemofiltration (CVVH) on Intra-abdominal Pressure and Kidney Function in Critically Ill Adults With Intra-abdominal Hypertension and Acute Kidney Injury
Enrollment Status: Withdrawn
Publish Date: December 15, 2022
Intervention Type: Procedure
Study Phase: Phase 3
Supplemental Corticosteroids in Cirrhotic Hypotensive Patients With Suspicion of Sepsis
Supplemental Corticosteroids in Cirrhotic Hypotensive Patients With Suspicion of Sepsis
Enrollment Status: Terminated
Publish Date: January 22, 2021
Intervention Type: Drug
Study Phase: Phase 3
REstricted Fluid Therapy VERsus Standard trEatment in Acute Kidney Injury - REVERSE-AKI Randomized Controlled Pilot Trial
REstricted Fluid Therapy VERsus Standard trEatment in Acute Kidney Injury - REVERSE-AKI Randomized Controlled Pilot Trial
Enrollment Status: Completed
Publish Date: December 14, 2020
Intervention Type: Other
Study Phase: Phase 2
A DB Four-Arm, Parallel Group, Proof of Concept, Dose-Finding Adaptive Phase 2a/2b RCT to Investigate the Safety, Tolerability and Efficacy and Effect on QoL of Human Recombinant Alkaline Phosphatase in Patients With Sepsis-Associated AKI
A DB Four-Arm, Parallel Group, Proof of Concept, Dose-Finding Adaptive Phase 2a/2b RCT to Investigate the Safety, Tolerability and Efficacy and Effect on QoL of Human Recombinant Alkaline Phosphatase in Patients With Sepsis-Associated AKI
Enrollment Status: Completed
Publish Date: March 23, 2020
Intervention Type: Other, Biological
Study Phase: Phase 2
View 7 Less Clinical Trials

134 Total Publications

Author Correction: Targeting ferroptosis protects against experimental (multi)organ dysfunction and death.
Author Correction: Targeting ferroptosis protects against experimental (multi)organ dysfunction and death.
Journal: Nature communications
Published: September 18, 2025
Similar Experts
Frederik H. Verbrugge
Expertise in
5
conditions
Frederik H. Verbrugge
Cardiology | Intensive Care Medicine
Expertise in
5
conditions
Frederik H. Verbrugge
Cardiology | Intensive Care Medicine

Universitair Ziekenhuis Brussel

101 Av. du Laerbeek, 
Jette, Bruxelles, BE 
 (28.0 miles away)

Frederik Verbrugge practices in Jette, Belgium. Mr. Verbrugge is highly rated in 5 conditions, according to our data. His top areas of expertise are Heart Failure, Heart Failure with Preserved Ejection Fraction (HFpEF), Low Sodium Level, Atrial Fibrillation, and Kidney Transplant.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Hoste's expertise for a condition
ConditionClose
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile